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This isolated working rat heart study was designed to investigate the effect 
of duration of reperfusion and degree of acidity of the reperfusate on 
myocardial protection. The experimental time course was as follows: 20 
minutes of perfusion with the heart working, 3 minutes of infusion with the 
St. Thomas' Hospital cardioplegic solution followed by global ischemia for 
33 minutes at 37 ° C, and 20 minutes of Langendorff reperfusion followed by 
20 minutes of working perfusion. During the initial 3 minutes of Langen- 
dorff reperfusion, the pH of the reperfusate was changed to 5.6, 6.8, and 7.5 
by addition of sodium hydroxide into Krebs-Henseleit nonbicarbonate 
HEPES buffer. A respiratory acidic reperfusate was used for the initial 0.5, 
1, 2, 3, 5, and 15 minutes during reperfusion. The results were as follows: 
(1) Reperfusion with a mildly acidic solution (i.e., pH 6.8) yielded better 
recovery than reperfusion with solutions having pH levels of 5.8 or 7.5. (2) 
Reperfusion for less than 3 minutes with a reperfusate having a pH level of 
6.8 provided better recovery, although reperfusion for longer than 3 
minutes exacerbated reperfusion injury. In conclusion, the effects of 
reperfusion with acidic solution were influenced by degree and duration 
with biphasic response characteristics. (J TrIORAC CARD1OVASC SURG 1996; 
111:613-20) 
R eperfusion injury of ischemic myocardium is an important problem in clinical and surgical situ- 
ations. In cardiac surgery, modification of reperfu- 
sate to protect against reperfusion injury is thought 
to be one of the important strategies to avoid 
reperfusion injury. 1-9 Recently, protective ffects of 
transient reperfusion with acidic solution have 
been reported by some investigators, 1°'11 although 
whether acidic reperfusion is protective is still con- 
troversial. The effects of acidosis on myocardium 
involve many factors such as ion exchange, ion 
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channels, energy metabolites, and affinity of calcium 
to troponinJ 2-15 These factors might affect more 
complicated influences on myocardium especially 
during reperfusion. Therefore the aim of this study 
of the isolated working rat heart was to investigate 
the optimal modification of the acidic reperfusate in
terms of the degree of acidity and the duration of 
reperfusion. The current study showed that tran- 
sient acidic reperfusion affected postischemic func- 
tional recovery with degree (pH level) and duration 
response characteristics. 
Materials and methods 
Experimental model (Fig. 1). Hearts were obtained 
from male Wistar rats (270 to 320 gm body weight). The 
isolated perfused working heart model is a left heart 
preparation in which oxygenated perfusion medium at 
37°C enters the cannulated left atrium at a pressure 
equivalent o 15 cm H20 and is passed to the left 
ventricle. It is spontaneously ejected (electrical pacing was 
not used in this study) from the left ventricle through an 
aortic cannula gainst a hydrostatic pressure quivalent to 
100 cm H20. Coronary effluent exits from the right side of 
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Fig. 1. Experimental model. The isolated perfused work- 
ing heart model is a left heart preparation in which 
oxygenated perfusion medium enters the cannulated left 
atrium at a pressure equivalent o 15 cm H20 and is 
passed to the left ventricle. It is spontaneously ejected 
from the left ventricle via an aortic cannula against a 
hydrostatic pressure quivalent to 100 cm H20. Coronary 
effluent exits from the right side of the heart and can be 
sampled for biochemical analysis or pooled and recircu- 
lated with the aortic flow. In the Langendorff mode, the 
left atrial cannula and arterial tube connected to the 
arterial chamber were clamped and the heart was per- 
fused in a retrograde fashion arterially from a reservoir 
located 100 cm above the heart. Ischemic cardiac arrest 
was induced by clamping the aortic cannula and left atrial 
cannula. 
the heart and can be sampled for biochemical nalysis or 
pooled and recirculated with the aortic flow. 
In the Langendorff nonworking mode, the atrial can- 
nula is clamped and perfusion fluid at 37 ° C is allowed to 
flow into the aorta from a reservoir located 100 cm above 
the heart. This preparation, originally described by Lan- 
gendorff, will continue to beat but does not perform 
external work, which is a condition similar to that pro- 
duced by total cardiopulmonary b pass during cardiac 
operations. Ischemic ardiac arrest can be induced in this 
preparation by clamping the aortic cannula. Short periods 
of preischemic coronary infusion (at 37 ° C) of cardiople- 
gic solution can be achieved by the use of a reservoir 
located 60 cm above the heart and attached to a side arm 
of the aortic cannula. During the period of global ischemia 
the heart is maintained in a sealed, temperature-regulated 
(37 ° C) chamber. 
Perfusion solution. The perfusion solution was the 
standard Krebs-Henseleit bicarbonate buffer solution con- 
taining (in millimoles per liter) NaC1, 118.5; NaHCO3, 25; 
KC1, 4.8; KH2PO4, 1.2; MgSO4, 1.2; 2.5 CaC12, 2.5; and 
glucose, 11. The control solution was adjusted to a pH of 
7.5 by equilibration with a gas mixture containing 5% 
carbon dioxide and 95% oxygen. Bicarbonate-free solu- 
tion, which was replaced by sodium chloride, contained a
10 mmol/L concentration of N-2-hydroxyethylpiperazine- 
N'-2-ethanesulfonic a id (HEPES) and was titrated with 
sodium hydroxide at 37 ° C to a pH of 7.4, 6.8, or 5.6. Also, 
the bicarbonate-free solution was saturated with 100% 
oxygen. Respiratory acidic solution was changed to pH 6.8 
by equilibration with a gas mixture containing 25% carbon 
dioxide and 75% oxygen. The cardioplegic solution was St. 
Thomas' Hospital cardioplegic solution No. 2 containing 
(in millimoles per liter) NaC1, 110; NaHCO3, 10; KC1, 16; 
MgC12, 16; and CaC12, 1.2. 
Basic protocol. Hearts were subjected to 5 minutes of 
Langendorff perfusion, 20 minutes of aerobic working 
perfusion, 3 minutes of cardioplegic infusion (at 37 ° C) 
with St. Thomas' Hospital cardioplegic solution, and 33 
minutes of ischemic arrest at 37 ° C. Hearts were then 
reperfused in the Langendorff mode for 20 minutes and 
then in the working mode for 20 minutes (37 ° C). 
Experimental protocol (Fig. 2) 
1. Pilot study. To exclude the possibilities of irreversible 
harmful effects of acidosis on the normoxic perfused 
heart, we perfused the hearts with respiratory acidic 
solution for 15 minutes followed by normal perfusion. 
2. pH study. During the initial 3 minutes of reperfusion 
after 33 minutes of normothermic schemia, during which 
the hearts were preserved with St. Thomas' Hospital 
cardioplegic solution, hearts were reperfused with HEPES 
buffered solution at three different pH levels (5.6, 6.8, and 
7.5). We selected bicarbonate-free HEPES buffer to main- 
tain the concentration of bicarbonate and carbon dioxide 
when pH was changed. 
3. Duration study. The duration of initial reperfusion 
with respiratory acidic solution (pH 6.8) was divided into 
six groups--0.5, 1, 2, 3, 5, and 15 minutes--and the results 
were compared with those in the control reperfusion 
group. We selected a Krebs-Henseleit bicarbonate buffer 
solution high in carbon dioxide, because this respiratory 
acidic solution has a rapid effect on myocardial pH. 16 
Measurement. Cardiac indices such as aortic flow, cor- 
onary flow, cardiac output, aortic pressure, heart rate, and 
stroke work were measured before and after the working 
period, and functional recoveries were expressed as per- 
centage of initial functional performances. Cardiac output 
was derived from the sum of the aortic flow and the 
coronary flow, and stroke work was calculated by multi- 
plying the cardiac output by the aortic pressure divided by 
the heart rate. Creatine kinase leakage into the coronary 
effluent during the initial 20-minute reperfusion period 
was measured by the Oliver U.V. method. 17 
Statistical analysis. Nine rats and 10 rats were used for 
the control group in the pH study and the duration study, 
respectively, and six rats were used for the other groups. 
Results were expressed as means +- standard error of the 
mean. All levels of statistical significance were calculated 
by means of analysis of variance in each study, and 
Dunnett's t tests were then performed. Values ofp < 0.05 
were considered to be significant. 
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Fig, 2. Experimental protocol. Hearts were subjected to 20 minutes of aerobic working perfusion, 3 
minutes of cardioplegic infusion with St. Thomas' Hospital cardioplegic solution, and 33 minutes of 
ischemic arrest at 37 + C. Hearts were then reperfused in the Langendorff mode for 20 minutes and then in 
the working mode for 20 minutes. During reperfusion, conditions of acidic reperfusion were modified in 
terms of pH level and duration. In the pH study, the pH of the reperfusion solution during the initial 3 
minutes of reperfusion was changed to 7.5, 6.8 and 5.6 of the bicarbonate-free HEPES buffered solution. 
In the duration study, duration of initial high carbon dioxide respiratory acidic reperfusion was changed to 
0.5, 1, 2, 3, 5, and 15 minutes. L, Langendorff perfusion; W, working perfusion; S, 3 minutes of infusion with 
St. Thomas' Hospital cardioplegic solution. 
Results 
1. Pilot study. Hearts subjected to acidic solution 
for 15 minutes recovered to pretreatment baseline 
levels and had no leakage of creatine kinase. 
2. pH study. Table I shows the preischemic ar- 
diac function in the pH study. No significant differ- 
ences were detected among these groups. Table II 
shows the functional recoveries of cardiac indices 
and creatine kinase leakage during reperfusion in 
the pH study. The hearts subjected to reperfusion 
with HEPES buffered solution at pH levels of 5.6, 
6.8, and 7.5 for the initial 3 minutes recovered to 
50.9% ± 3.2%, 65.9% ± 1.8%, and 57.8% ± 1.5% 
of preischemic cardiac output, respectively (Fig. 3). 
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Tab le  I. Pre&chemic ardiac function (pH study) 
Aortic 
Aortic flow Coronary flow Cardiac output pressure Heart rate Stroke work 
pH (ml/min) (ml/min) (ml/min) (cm H20 ) (beats~rain) (105 dyne • cm/beat) 
5.6 (n = 6) 74.4 _+ 1.5 21.2 _+ 0.6 95.6 -+ 2.0 186 +- 2 299 ± 13 59.7 + 2.3 
6.8 (n = 6) 76.4 _+ 2.4 23.0 +- 1.5 99.5 -- 3.4 189 -+ 6 309 _+ 15 61.3 _+ 4.2 
7.5 (n = 9) 74.2 -+ 2.2 21.2 + 1.0 95.5 + 2.9 188 + 3 302 _+ 10 59.8 _+ 2.0 
Values are means -+ standard error of the mean. 
Table II. Postischemic functional recovery and creatine kinase leakage (pH study) 
Creatine kinase 
Aortic flow Coronary flow Cardiac output Aortic pressure Heart rate Stroke work leakage 
pH (%) (%) (%) (%) (%) (%) (IU/gm dry wt) 
5.6 (n = 6) 45.5 _+ 3.8 70.2 --+_ 2.2 50.9 ± 3.2 85.8 -- 2.1 91.8 _+ 2.8 48.2 ± 4.5 35.3 -+ 4.5 
6.8 (n = 6) 60.1 ± 2.1" 84.9 ± 1.4" 65.9 ± 1.8" 88.4 _+ 1.8 93.9 ± 2.0 62.4 _+ 3.7* 12.1 ± 2.0* 
7.5 (n = 9) 51.9 ± 2.1 78.2 --_ 2.1" 57.8 ± 1.57 88.6 ± 1.0 91.4 ± 1.3 56.0 _+ 1.2 40.9 +- 4.9? 
Values are means -+ standard error of the mean. 
*Values at pH 6.8 vs pH 5.6, p < 0.05. 
~Values at pH 7.5 vs pH 6.8, p < 0.05. 
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Fig. 3. Percent recovery of cardiac output in the pH 
study. 
The percent recovery of cardiac output was highest 
in the hearts reperfused at a pH of 6.8 and lowest in 
those reperfused at a pH of 5.6. The changes reach 
statistical significance. Creatine kinase leakage dur- 
ing the initial 15 minutes of reperfusion i the hearts 
reperfused at a pH of 6.8 was the lowest• 
3. Duration study. Table III shows preischemic 
cardiac function in the duration study. No significant 
differences were detected among these groups• Ta- 
ble IV shows the functional recoveries of cardiac 
indices and creatine kinase leakage during reperfu- 
sion. Varying the duration of reperfusion with re- 
spiratory acidic solution (pH 6.8) resulted in a 
biphasic time-response functional recovery. In the 
hearts reperfused with control Krebs-Henseleit bi- 
carbonate buffer solution with a pH of 7.5, cardiac 
output recovered to 54.0% + 0.7%. The hearts 
reperfused with acidic solution for an initial 0.5, 1, 2, 
3, 5, or 15 minutes recovered to 51.7% _+ 3.3%, 
64.5% _ 3.8% (p < 0.05 vs control), 59.8% _+ 3.6%, 
56.7% _+ 1.9%, 43.1% _+ 2.9% (p < 0.05 vs control), 
and 43.6% _+ 2.4% (p < 0.05 vs control) of preisch- 
emic control values, respectively (Fig. 4). Recoveries 
of aortic flow in the hearts subjected to acidic 
reperfusion for 0.5, 1, 2, 3, 5 or 15 minutes were 
44.8% _+ 4.0%, 58.0% _+ 4% (p < 0.05 vs control 
[45.7% _+ 0.6%]), 55.8% +_ 4.2% (p < 0.05 vs 
control [45.7% +_ 0.6%]), 52.8% +_ 2.7%, 37.1% _+ 
3.5% (p < 0.05 vs control [45.7% _+ 0.6%]), and 
35.7% _+ 2.6% (/9 < 0.05 vs control [45.7% _+ 
0.6%]), respectively. When acidic reperfusion was 
used for less than 3 minutes, percent recovery of 
cardiac output was greater than with control reper- 
fusion. However, in the hearts reperfused with 
acidic solution for more than 3 minutes, recovery 
was poorer than with control reperfusion. Creatine 
kinase leakage during 15 minutes of reperfusion was 
reflected by the percent recovery of cardiac func- 
tion, although the difference was not statistically 
significant. 
Discuss ion  
During cardiac operations, optimizing the extra- 
cellular environment during reperfusion can help to 
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Table III. Preischemic ardiac function (duration study) 
Duration Aorttc flow Coronary flow Cardiac output Aortic pressure Heart rate Stroke work 
(rain) (ml/mb 0 (ml/rnin) (ml/min) (cm H20 ) (beats/min) (lO s dyne • cm/beat) 
Control  (n 10) 73.2 + 2.2 21.0 ± 1.1 94.0 _+ 2.6 212 ± 6 308 _+ 8 64.8 ± 2.2 
0.5 (n = 6) 76.0 ± 2.7 22.8 _+ 0.9 98.8 -+ 3.6 205 _+ 4 308 _+ 6 65.7 ± 2.7 
1 (n = 6) 70.7 + 2.6 23.2 ± 1.2 93.7 -+ 3.6 237 _+ 7 311 _+ 13 68.3 -+ 2.0 
2 (n = 6) 78.2 ± 2.5 21.2 ± 1.1 99.2 + 3.2 190 ± 6 296 _+ 10 63.9 ± 2.1 
3 (n = 6) 75.9 _+ 2.5 20.1 _+ 1.1 95.9 ± 3.3 t86 _+ 5 319 _+ 13 61.6 _+ 3.2 
5 (n = 6) 77.1 _+ 1.1 22.7 _+ 0.6 99.7 ± 1.2 192 _+ 5 307 ± 8 62.8 _+ 2.6 
15 (n : 6) 75.3 ± 2.8 21.4 ± 0.6 96.6 + 2.8 187 _+ 4 324 ± 9 59.3 -+ 4.4 
Values are means _+ standard error of the mean. 
Table IV. Postischemic functional recovery and creatine kinase leakage (duration study) 
Creatine kinase 
Duration Aortic flow Coronary flow Cardiac output Aortic pressure Heart rate Stroke work leakage 
(min) (%) (%) (%) (%) (%) (%) (IU/gm dry wt) 
Control  (n = 10) 45.7 _+ 0.6* 76.9 _+ 1.4" 54.0 _+ 0.7* 87.8 ± 2.1 92.0 _+ 2.0* 51.5 ± 1.7" 42.0 + 8.4 
0.5 (n = 6) 44.8 _+ 4.0? 74.0 -+ 4.0? 51.7 _+ 3.3? 84.2 ± 2.2 91.0 ± 3.2 48.8 _+ 6.0t 52.7 _+ 14.8 
1 (n = 6) 58.0 ± 4.15 82.7 _+ 3.3:I: 64.5 ± 3.85 95.8 ± 2.4 92.7 ± 3.4~- 67.2 ± 5.3§ 38.8 ± 9.4 
2 (n - 6) 55.8 -+ 4.2§ 74.0 _+ 1.7§ 59.8 _+ 3.6§ 91.8 + 2.4 88.2 ± 3.3 62.0 _+ 3.61[ 21.8 ± 5.3 
3 (n = 6) 52.8 -+ 2.711 71.8 -+ 2.01[ 56.7 2 1.911 85.8 ± 2.6 96.6 + 4.1§ 45.1 + 3.2 36.1 ± 13.4 
5 (n = 6) 37.1 ± 3.5 64.4 -+ 2.3 43.1 -+ 2.9 83.4 ± 0.9 86.7 _+ 3.0 41.8 ± 3.0 44.6 ± 12.7 
15 (n = 6) 35.7 + 2.6 71.1 -+ 2.1 43.6 ± 2.4 88.9 ± 2.1 83.4 ± 2.0 46.2 ± 1.8 46.1 ± 3.4 
Values are means _+ standard error of the mean. 
Aortic flow: *p < 0.05 versus 1, 2, 5, and 15 minutes; ~p < 0.05 versus l, 2, 5, and 15 minutes; :~p < 0.05 versus 5 and 15 minutes; §p < 0.05 versus 5 and 
15 minutes; lip < 0.05 versus 5 and 15 minutes. 
Coronary flow: *p < 0.05 versus 5 minutes; tp < 0.05 versus 1 and 5 minutes; :~p < 0.05 versus 2, 3, 5, and 15 minutes; §p < 0.05 versus 5 and 15 minutes; 
PIP < 0.05 versus 5 and 15 minutes. 
Cardiac output: *p < 0.05 versus 1, 5, and 15 minutes; tp < 0.05 versus 1, 5, and 15 minutes; Sp < 0.05 versus 5 and 15 minutes; §p < 0.05 versus 5 and 15 
minutes; liP < 0.05 versus 5 and 15 minutes. 
Heart rate: *p < 0.05 versus 15 minutes; tp < 0,05 versus 15 minutes; §p < 0.05 versus 5 and 15 minutes. 
Stroke work: *p < 0.05 versus 1, 2, and 5 minutes; ?p < 0.05 versus 2 minutes; §p < 0.05 versus 3, 5, and 15 minutes: lip < 0.05 versus 3, 5, and 15 minutes. 
avoid reperfusion i n ju ry .  1-9 Un l ike  cardioplegic so- 
lutions, whose compositions have been widely inves- 
tigated,iS, 19 the optimal pH of reperfusion solutions 
has not been widely investigated. 3'4' 11 Our study 
was designed to evaluate the effects of extracellular 
modification of pH on ischemic myocardium pre- 
served with St. Thomas' Hospital cardioplegic solu- 
tion in terms of functional recovery and creatine 
kinase leakage. 
The optimal pH of bicarbonate-free HEPES 
buffer solution for the initial 3 minutes of reperfu- 
sion to protect against reperfusion injury was 6.8. 
Recovery was better in the hearts reperfused with 
respiratory acidic solution within 3 minutes than in 
control hearts, but reperfusion for longer than 3 
minutes was harmful. Thus for 3 minutes the effects 
of acidic reperfusion on postischemic hearts were 
significantly influenced by degree of acidosis (pH 
level) and duration of perfusion. In the pH study, we 
selected bicarbonate-free HEPES buffer to maintain 
the concentration f bicarbonate and carbon dioxide 
when pH was changed. In the duration study, we 
selected a Krebs-Henseleit bicarbonate buffer solu- 
tion with a high carbon dioxide content, because this 
respiratory acidic solution has a rapid effect on 
myocardial pH.16 The different types of acidic solu- 
tions might have different influences on myocardi- 
urn.z0, 21 In our previous tudy, we found that hearts 
reperfused with bicarbonate-flee HEPES buffer re- 
covered better than those reperfused with bicarbon- 
ate buffer. This suggests that bicarbonate-dependent 
intracellular pH regulation was one of the factors 
that alter reperfusion i jury. 22 In this respect, if we 
had chosen the bicarbonate-free HEPES buffer in- 
stead of the respiratory acidic solution in the dura- 
tion study, we would not have obtained the same 
results. However, we believe that we obtain almost 
the same biphasic duration-response characteristics 
with the acidic reperfusate. 
Previous reports considering modification of pH 
in reperfusate. In the early 1980s Follette and co- 
workers 1'3 reported that raising pH to 7.8 in the 
reperfusate during the initial 5 minutes of reperfu- 
sion improved functional recovery of hypothermic 
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Fig. 4. Percent recovery of cardiac output in the duration study. 
ischemic dog hearts. It has since been widely ac- 
cepted that the optimal and reasonable modification 
of extracellular pH to salvage the ischemic heart is 
to make the pH more alkaline, which immediately 
neutralizes the acidosis of the ischemic myocardium. 
Similarly, Menasch6 and coworkers 4 reported that 
in the isolated perfused rat heart after 2 hours of 
cardioplegic arrest, a glutamate-buffered reperfu- 
sate at pH 7.7 for 3 minutes provided better recov- 
ery of cardiac performance than the same buffer at 
pH 7.4. They also reported the protective effect of 
asanguineous reperfusion solutions in the clinical 
situation. 5 Milliken, Billingsley, and Laks 6 reported 
the protective ffect of modified reperfusate (potas- 
sium 22 millimoles per liter, pH 7.8) for 10 minutes 
on a canine heart subjected to prolonged hypother- 
mia. However recently, Kitakaze, Weisfeldt, and 
\ . . 
Marban 1° demonstrated that transient acidic reper- 
fusion (an initial 3 minutes at a pH of 6.6 and after 
2 minutes at a pH of 7.0) prevented myocardial 
stunning in ferret hearts made ischemic for 15 
minutes. Similarly, Avkiran and Ibuki 11 reported 
that transient reperfusion with acidic solution 
helped to prevent reperfusion-induced arrhythmia. 
Hori and coworkers 23 observed that acidosis during 
staged reperfusion attenuated myocardial stunning 
in dogs. Harada and associates 24 contributed the 
protective effect of acidic solution to prevent an 
increase in intracellular calcium during reperfusion. 
The discrepancy in these results is attributable not 
only to a difference in experimental species and mod- 
els but also to the many different conditions of acidic 
reperfusion. Our result, demonstrating that the effects 
of acidic reperfusion are influenced by the different 
conditions, is consistent with previous reports. 
Protective effects of mildly acidic solutions and 
short periods of reperfusion. The possible mecha- 
nism of the protective effect of acidic solutions is 
thought to be the prevention of calcium overload 
during reperfusion. At the onset of reperfusion, a 
rapid increase in intracellular pH is associated with 
sodium intrusion by way of sodium-proton ex- 
change. 25-28 An increase in the intracellular concen- 
tration of sodium ion that cannot be pumped out of 
a cell as a consequence of the depression of sodium 
potassium adenosinetriphosphatase leads to massive 
calcium intrusion by a sodium-calcium exchange. 29' 30 
Consequently sodium-calcium exchange and sodium- 
proton exchange induced by proton extrusion from 
acidic myocardium play key roles in myocardial injury 
during reperfusion. This is called the pHparadox. 27' z~ 
Acidosis, which is thought to inhibit both sodium- 
proton exchange and sodium-calcium exchange, 31 pre- 
vents an overload of sodium and calcium by inhibition 
of these exchanges. 24 In addition, acidosis influences 
the decrease in the accumulation of intracellular cal- 
cium via a calcium inward current 32 and a calcium- 
induced calcium release from the sarcoplasmic reticu- 
lum.14,  33 Therefore slowing or delaying of pH recovery 
by acidic reperfusion is thought to help to prevent the 
pH paradox and to attenuate calcium overload. I°' ~i, 26 
Second, an important possible protective mecha- 
nism of acidic reperfusion is the reduction of the 
calcium-binding ability of troponin. 34' 35 During reper- 
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fusion, myocardial rigor caused by intracellular cal- 
cium overload might be prevented because of reduc- 
tion of the calcium-binding ability of troponinJ 3
Third, acidosis is thought o decrease the energy 
demand and reduce the use Of adenosine triphos- 
phate by reducing the heart contractility, l°'12 
Since Bing, Brooks, and Messer 36 reported the 
protective ffect of acidosis on the hypoxic rat heart, 
the protective ffect of mild acidosis has been ob- 
served by many other investigators. 36-38 Koop and 
Piper 37 demonstrated that mild acidosis (around pH 
7.0) had a prominent energy-saving effect on the 
hypoxic heart. Bak and Ingwal139 suggested that 
inhibition of 5'-nucleotidase byacidosis during isch- 
emia preserved adenosine triphosphate and pre- 
vented reperfusion injury. 
Harmful effects of severely acidic solutions and 
longer periods of reperfusion. The most important 
point in the current results is that reperfusion of 
acidic solution has biphasic and opposite ffects on 
the heart after ischemia. Although acidic reperfu- 
sion has been reported to attenuate reperfusion 
injury, our observation showed that a severely acidic 
reperfusate or longer periods of acidic reperfusion 
had a detrimental effect on the reperfused heart. 
Acidosis in general suppresses many metabolic 
pathways that are essential to maintain homeostasis 
of myocardium, including sodium-potassium adeno- 
sinetriphosphatase activity. 12 In this respect, the 
inhibition of a sodium pump by acidosis during 
reperfusion may have detrimental effects on post- 
ischemic myocardium. We observed that a long 
period of reperfusion with acidic solution was det- 
rimental. Myocardial recovery isbetter if the start of 
pH recovery (pH paradox) is delayed for 3 minutes, 
although inhibition of metabolism for more than 3 
minutes during reperfusion may be harmful. 
Interestingly, Allen and Orchard 13 demonstrated 
that the response of myocardium to acidosis was 
influenced by duration. In the myocardium sub- 
jected to acidic perfusion at an early phase, a 
decrease of calcium binding to troponin and a 
decrease of calcium release from sarcoplasmic retic- 
ulum were observed. At a late phase, calcium over- 
load caused by a calcium release from the troponin 
binding site replaced by hydrogen was observed. The 
bell-shaped uration response curve observed in our 
acidic reperfusion study supports their observation. 
Limitation of this study. Several limitations of 
this study should be addressed. This study was 
conducted in the asanguineous i olated rat heart 
preparation. Recent work 4° suggested that a blood- 
perfused heart is more closely related to the clinical 
situation than a crystalloid-perfused heart. It is 
recognized that the blood-perfused heart is different 
from the crystalloid-perfused heart in terms of the 
buffering capacity, hormonal effect, viscosity, white 
blood cell count, and other blood-containing factors. 
However, the blood-containing factors may not have 
an adverse influence on the effect of acidic reperfu- 
sion, which is mainly mediated by ion exchange 
systems and intracellular functions, as discussed 
earlier. Further studies of a blood-perfused model 
and in vivo model will be necessary before this 
technique can be applied clinically. Furthermore, 
Krebs-Henseleit bicarbonate buffer used in this 
study has been widely used for cardiac research; 
however, the concentration of calcium (2.5 milli- 
moles per liter) and pH (7.5) may not be relevant to 
the clinical situation. In addition, we used normo- 
thermic global ischemia with St. Thomas' Hospital 
cardioplegic solution as the myocardial protectant. 
It is conceivable that a different ype of myocardial 
protection may produce different results. 
Conclusion 
After normothermic global ischemia of rat hearts 
and preservation with the St. Thomas' Hospital 
cardioplegic solution, transient reperfusion with 
acidic solution affected postischemic functional re- 
covery with biphasic duration and degree response 
characteristics. Brief reperfusion (within 3 minutes) 
with mildly acidic solution (pH 6.8) had protective 
properties; prolonged reperfusion (more than 3 
minutes) with severely acidic solution (pH 5.6) was 
harmful compared with control reperfusion. To our 
knowledge, no other reports assessing the modula- 
tion of acidic reperfusion have been published. As a 
result of our study, when we use reperfusion solu- 
tion or terminal cardioplegia (hot shot) in patients, 
we must consider both duration of reperfusion and 
acidity of the solution. 
We thank Dr. George Smith for assistance in preparing 
the manuscript. 
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